Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.

导出 LinkOut

翻译打印收藏纠错

作者： Congcong,Zhang ^[1] ; Pranav,Oberoi ^[2] ; Sarah,Oelsner ^[3] ; Anja,Waldmann ^[1] ; Aline,Lindner ^[1] ; Torsten,Tonn ^[1] ; Winfried S,Wels ^[1]

作者单位： Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany. ^[1] German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany. ^[2] German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[3] German Red Cross Blood Donation Service North-East, Institute for Transfusion Medicine, Dresden, Germany. ^[4] Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany. ^[5] German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany. ^[6]

关键词 NK-92 adoptive cancer immunotherapy chimeric antigen receptor leukemia lymphoma natural killer cells solid tumors

DOI 10.3389/fimmu.2017.00533

PMID 28572802

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览48

Frontiers in immunology

2017年8卷

533页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

检索历史清除